Azenta, Inc. (AZTA)
NMS · Medical Instruments & Supplies
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Peers in Medical Instruments & Supplies
All in industry →Intuitive Surgical, Inc.
Medline Inc.
Becton, Dickinson and Company
Alcon Inc.
ResMed Inc.
West Pharmaceutical Services, Inc.
The Cooper Companies, Inc.
Align Technology, Inc.
Solventum Corporation
Baxter International Inc.
Recent press releases
April 2026
Azenta, Inc. — 8-K Filing
# 🧾 What This Document Is This is an **8-K filing**, which is a report companies file with the SEC to announce major events that shareholders should know about. Specifically, this filing contains the **official employment offer letter** and associated **confidentiality/non-compete agreements** for
SEC filings
All filings →Insider trades
All insider trades →Azenta, Inc. has no reported insider trades in the last 90 days.